BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32752566)

  • 1. Hepatitis A and B Vaccination in the United States.
    Sanchez MC
    R I Med J (2013); 2020 Aug; 103(6):44-46. PubMed ID: 32752566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
    BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
    Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
    Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heplisav-B vaccination for the prevention of hepatitis B virus infection in adults in the United States.
    Splawn LM; Bailey CA; Medina JP; Cho JC
    Drugs Today (Barc); 2018 Jul; 54(7):399-405. PubMed ID: 30090877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
    Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
    Proell S
    BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
    [No Abstract]   [Full Text] [Related]  

  • 12. [The immunological effectiveness and reactogenicity of the vaccine "HEP-A+B-in-VAC" against hepatitis A and B].
    Chuĭkova KI; Gordetskaia EL; Gorbunov MA; Maĭdaniuk AG; Pomytkina MI
    Vopr Virusol; 2006; 51(1):31-3. PubMed ID: 16515040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and A vaccination in HIV-infected adults: A review.
    Mena G; García-Basteiro AL; Bayas JM
    Hum Vaccin Immunother; 2015; 11(11):2582-98. PubMed ID: 26208678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A breakthrough case of hepatitis A disease following a full vaccination schedule of three doses of a combined hepatitis A and B vaccine.
    Nothdurft HD; Aumüller H; Aumüller R; Dames W; Stamer K; Kroetzsch H; Kulow M
    Vaccine; 2004 Jan; 22(5-6):592-3. PubMed ID: 14994738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Response to hepatitis A and hepatitis B vaccination: genetic differences].
    Degos F
    Gastroenterol Clin Biol; 2003 Apr; 27(4):429-30. PubMed ID: 12759691
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
    Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new accelerated vaccination schedule for rapid protection against hepatitis A and B.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Vollmar J; Sänger R
    Vaccine; 2002 Jan; 20(7-8):1157-62. PubMed ID: 11803077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.